ACS chemical neuroscience molecule spotlight on telcagepant (MK-0974)

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Telcagepant (MK-0974) is a novel calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/research/pipeline/home.html). MK-0974 is currently being studied in phase III clinical trials.

Original languageEnglish (US)
Pages (from-to)334-335
Number of pages2
JournalACS Chemical Neuroscience
Volume2
Issue number7
DOIs
StatePublished - Jul 20 2011

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Fingerprint Dive into the research topics of 'ACS chemical neuroscience molecule spotlight on telcagepant (MK-0974)'. Together they form a unique fingerprint.

  • Cite this